Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Dutasteride: 0.5mg Oral Dutasteride to be given Alternate Day for 6 months
Control Intervention1: Dutasteride: 0.5mg Oral Dutasteride to be given Once Daily for 6 months
Sponsors
Dr Neil Patel
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed patients of androgenic alopecia not on any treatment in past 3 months 2. Patients willing to follow instruction and give informed consent
Exclusion criteria
Exclusion criteria: 1. Previous allergic reactions to finasteride like compounds 2. Prior surgical correction of scalp hair loss 3. Patients with any other inflammatory/scarring lesion on scalp 4. Patients with chronic systemic illness (Tuberculosis, HIV) 5. Patients on drugs with significant interaction with dutasteride (CYP3A4 inducers/inhibitors) 6. Patients with cancer or first degree relative with prostate cancer before the age of 50
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density, Hair diameterTimepoint: 1 month, 3 months, 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of ADRs assessed by WHO-UMC causality scaleTimepoint: 1 month, 3 months, 6 months | — |
Countries
India
Contacts
Public ContactDr Farida Ahmad
Jawaharlal Nehru Medical College
Outcome results
None listed